Wall Street brokerages expect that Prestige Consumer Healthcare Inc (NYSE:PBH) will report earnings per share (EPS) of $0.63 for the current fiscal quarter, according to Zacks Investment Research. Four analysts have provided estimates for Prestige Consumer Healthcare’s earnings, with the lowest EPS estimate coming in at $0.62 and the highest estimate coming in at $0.63. Prestige Consumer Healthcare posted earnings per share of $0.61 during the same quarter last year, which would indicate a positive year-over-year growth rate of 3.3%. The business is expected to announce its next earnings report on Thursday, November 1st.

According to Zacks, analysts expect that Prestige Consumer Healthcare will report full-year earnings of $2.86 per share for the current fiscal year, with EPS estimates ranging from $2.83 to $2.90. For the next year, analysts forecast that the firm will report earnings of $3.06 per share, with EPS estimates ranging from $2.97 to $3.17. Zacks’ earnings per share calculations are a mean average based on a survey of research analysts that follow Prestige Consumer Healthcare.

Prestige Consumer Healthcare (NYSE:PBH) last announced its quarterly earnings results on Thursday, August 2nd. The company reported $0.68 EPS for the quarter, beating the Zacks’ consensus estimate of $0.67 by $0.01. Prestige Consumer Healthcare had a return on equity of 12.45% and a net margin of 32.76%. The firm had revenue of $253.98 million for the quarter, compared to analyst estimates of $253.70 million. During the same period last year, the firm posted $0.66 earnings per share. The business’s revenue for the quarter was down 1.0% on a year-over-year basis.

A number of analysts have recently commented on PBH shares. Zacks Investment Research lowered Prestige Consumer Healthcare from a “hold” rating to a “strong sell” rating in a research note on Tuesday, July 10th. Jefferies Financial Group set a $38.00 price target on Prestige Consumer Healthcare and gave the company a “hold” rating in a research note on Thursday, August 2nd. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and four have given a buy rating to the stock. Prestige Consumer Healthcare has an average rating of “Hold” and a consensus target price of $69.00.

Shares of PBH stock traded down $0.61 during mid-day trading on Wednesday, reaching $38.08. 615,100 shares of the stock traded hands, compared to its average volume of 741,207. Prestige Consumer Healthcare has a 1-year low of $27.84 and a 1-year high of $51.79. The firm has a market capitalization of $1.99 billion, a price-to-earnings ratio of 15.04, a PEG ratio of 1.92 and a beta of 1.04. The company has a current ratio of 2.21, a quick ratio of 1.37 and a debt-to-equity ratio of 1.72.

Hedge funds have recently made changes to their positions in the company. Royal Bank of Canada lifted its stake in shares of Prestige Consumer Healthcare by 81.4% in the first quarter. Royal Bank of Canada now owns 2,027,327 shares of the company’s stock worth $68,362,000 after acquiring an additional 909,507 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of Prestige Consumer Healthcare by 37.7% in the second quarter. Dimensional Fund Advisors LP now owns 3,199,714 shares of the company’s stock worth $122,805,000 after acquiring an additional 876,192 shares during the period. FMR LLC lifted its stake in shares of Prestige Consumer Healthcare by 17.2% in the second quarter. FMR LLC now owns 5,880,226 shares of the company’s stock worth $225,683,000 after acquiring an additional 864,847 shares during the period. Champlain Investment Partners LLC lifted its stake in shares of Prestige Consumer Healthcare by 57.5% in the first quarter. Champlain Investment Partners LLC now owns 1,774,055 shares of the company’s stock worth $59,821,000 after acquiring an additional 647,440 shares during the period. Finally, Fuller & Thaler Asset Management Inc. lifted its stake in shares of Prestige Consumer Healthcare by 47.9% in the second quarter. Fuller & Thaler Asset Management Inc. now owns 1,986,867 shares of the company’s stock worth $76,256,000 after acquiring an additional 643,312 shares during the period.

Prestige Consumer Healthcare Company Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Featured Article: Index Funds

Get a free copy of the Zacks research report on Prestige Consumer Healthcare (PBH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.